Sanofi shares down despite $13 billion Regeneron payday


Sanofi shares down despite $13 billion Regeneron payday
Shares in Sanofi fell on Tuesday despite the French drugmaker’s impending $13 billion payday from selling most of its 20.6% stake in U.S. partner Regeneron .


Sanofi shares down despite $13 billion Regeneron payday
Shares in Sanofi fell on Tuesday despite the French drugmaker’s impending $13 billion (£10.56 billion) payday from selling most of its 20.6% stake in U.S. partner Regeneron .


Sanofi Shares Down Despite $13 Billion Regeneron Payday
TodayPARISShares in Sanofi fell on Tuesday despite the French drugmaker’s impending $13 billion payday from selling most of its 20.6% stake in U.S. partner Regeneron. By 1111 GMT, shares in Sanofi


Sanofi shares down despite US$13 billion Regeneron payday
Shares in Sanofi fell on Tuesday despite the French drugmaker’s impending US$13 billion payday from selling most of its 20.6per cent stake in U.S. partner Regeneron . FILE PHOTO: The logo of …


Sanofi shares down despite $13 billion Regeneron payday
Shares in Sanofi fell on Tuesday despite the French drugmaker’s impending $13 billion payday from selling most of its 20.6% stake in U.S. partner Regeneron . The stake sale, part of a major …


Sanofi shares down despite $13 billion Regeneron payday
Shares in Sanofi fell on Tuesday despite the French drugmaker’s impending $13 billion payday from selling most of its 20.6% stake in U.S. partner Regeneron. By 1111 GMT, shares in Sanofi were down


Sanofi shares down despite $13 billion Regeneron payday
Shares in Sanofi fell on Tuesday despite the French drugmaker’s impending $13 billion (£10.56 billion) payday from selling most of its 20.6% stake in U.S. partner Regeneron . The stake sale, part of a major overhaul under new CEO Paul Hudson, will see Regeneron repurchase $5 billion of its stock


Macy’s announces $1 billion bond offering to repay credit …
The department store chain drew down a $1.5 billion credit facility in March as it had to temporarily close stores and limit its business to its app and website due to the COVID-19 pandemic. A …


Sanofi shares down despite $13 billion Regeneron payday
PARIS (Reuters) – Shares in Sanofi (SASY.PA) fell on Tuesday despite the French drugmaker’s impending $13 billion payday from selling most of its 20.6% stake in U.S. partner Regeneron (REGN.O). FILE PHOTO: The logo of Sanofi is seen at the company’s headquarters in Paris, France, April 24, 2020. REUTERS/Charles Platiau/File Photo By 1111 GMT, shares in Sanofi were down 1%,…


Sanofi shares down despite $13 billion Regeneron payday
Shares in Sanofi fell on Tuesday despite the French drugmaker’s impending $13 billion (£10.56 billion) payday from selling most of its 20.6% stake in U.S. partner Regeneron.. By 1111 GMT, shares in Sanofi were down 1%, in line with the broader European health index. The stake sale, part of a major overhaul under new CEO Paul Hudson, will see Regeneron repurchase $5 billion of its stock with …